Stay updated on Liraglutide in Prader-Willi Syndrome: Pediatric Weight Clinical Trial
Sign up to get notified when there's something new on the Liraglutide in Prader-Willi Syndrome: Pediatric Weight Clinical Trial page.

Latest updates to the Liraglutide in Prader-Willi Syndrome: Pediatric Weight Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding outage notice and Revision: v3.4.1.SummaryDifference0.3%

- Check41 days agoChange DetectedA site-wide notice about potential data delays due to a lapse in government funding has been added. The page revision tag has been updated to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check48 days agoChange DetectedShow glossary feature has been added. QC metadata labels have been updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the page revision shows 'Revision: v3.4.0'.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Revision: v3.3.4; Deleted Revision: v3.3.3.SummaryDifference0.0%

- Check83 days agoChange DetectedIntroduced a consolidated 'Locations' section listing study sites in California, Maryland, New York, Ohio, New South Wales, Victoria, Alberta, and Quebec. Updated the page revision to v3.3.3 and replaced prior country-specific location blocks.SummaryDifference0.6%

Stay in the know with updates to Liraglutide in Prader-Willi Syndrome: Pediatric Weight Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Liraglutide in Prader-Willi Syndrome: Pediatric Weight Clinical Trial page.